Periodic Reporting for period 1 - OPTIMIsE (Commercial feasibility of the Novio-PlainGel: a novel synthetic, reversible thermosensitive, biomimetic hydrogel for organoid-based precision medicine)

A common challenge of cancer treatment is a lack of effective therapies. For example, there is no adequate cure for pancreatic cancer and the survival rate is extremely low. The use of organoids is considered to be the solution to accelerate the development of new therapies...